MeSH term
Frequency | Condition_Probility | Female | 5 | 0.0 |
Humans | 26 | 0.0 |
Multivariate Analysis | 2 | 0.0 |
NF-kappa B/*genetics | 7 | 15.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Genes, Structural | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein Binding | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Gene Rearrangement | 3 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Animals | 12 | 0.0 |
Comparative Study | 4 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Mice | 5 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Transfection | 4 | 0.0 |
Base Sequence | 12 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Binding Sites | 5 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
NF-kappa B/*biosynthesis | 2 | 14.0 |
Proto-Oncogene Proteins/biosynthesis | 2 | 1.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Proto-Oncogene Proteins c-rel | 5 | 8.0 |
Cell Line | 9 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Epithelium/metabolism | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
*I-kappa B | 6 | 3.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
DNA/metabolism | 3 | 0.0 |
*Chromosomes, Human, Pair 14 | 2 | 1.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
DNA | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
*Chromosomes, Human, Pair 4 | 2 | 0.0 |
